Literature DB >> 16926465

Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.

Pallab Ray1, Jyoti Sharma, Rungmei S K Marak, R K Garg.   

Abstract

BACKGROUND AND OBJECTIVES: Resistance in Salmonella enterica var Typhi (S. Typhi) to chloramphenicol, amoxicillin and co-trimoxazole has posed a challenge to treatment of typhoid fever. Ciprofloxacin has been the empirical therapy of choice, but the recent increase in minimum inhibitory concentration (MIC) to ciprofloxacin in S. Typhi, not detectable by disc diffusion (DD) tests, may result in delayed response and serious complications. Nalidixic acid (NA) resistance has been used as an indirect evidence of increased ciprofloxacin MIC in S. Typhi. We evaluated the predictive value of NA resistance for fluoroquinolone resistance in clinical isolates of S. Typhi.
METHODS: A total of 70 clinical isolates of S. Typhi were tested for antimicrobial susceptibility according to the National Committee for Clinical Laboratory Standards (NCCLS) method. MIC to fluoroquinolones was carried out by the agar dilution method.
RESULTS: Thirteen (18.6 %) isolates were resistant to amoxicillin, chloramphenicol and cotrimoxazole; all were sensitive to ciprofloxacin and cefotaxime. Fifty (71.4%) were resistant to NA. Nineteen (27.1 %) isolates were resistant to ciprofloxacin by MIC tests. The MIC for ciprofloxacin was 0.03-4 microg/ml for NA(S) and 0.25-4 microg/ml for NA(R) isolates. NA susceptibility showed a predictive value of 95 per cent for ciprofloxacin susceptibility while NA resistance had a predictive value of 36 per cent for ciprofloxacin resistance. Thirty isolates studied were sensitive to gatifloxacin; MIC values were 0.03-0.5 microg/ml for NA(S) and 0.25-0.5 microg/ml for NA(R) isolates. INTERPRETATION AND
CONCLUSION: NA susceptibility was a good marker for fluoroquinolone susceptibility but NA resistance had a poor predictive value for ciprofloxacin resistance. NA resistant isolates should be tested for ciprofloxacin MIC before deciding a change in therapeutic regimen. Higher MIC for gatifloxacin was also noticed in NA resistant isolates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926465

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  9 in total

1.  Clinical and Laboratory Profile of Enteric Fever in Children From a Tertiary Care Centre in Odisha, Eastern India.

Authors:  Jyoti Ranjan Behera; Amit R Rup; Arun K Dash; Sanjay Kumar Sahu; Abhinav Gaurav; Abhas Gupta
Journal:  Cureus       Date:  2021-01-20

2.  Antimicrobial Drug Resistance of Vibrio cholerae, Democratic Republic of the Congo.

Authors:  Berthe Miwanda; Sandra Moore; Jean-Jacques Muyembe; Georges Nguefack-Tsague; Ickel Kakongo Kabangwa; Daniel Yassa Ndjakani; Ankur Mutreja; Nicholas Thomson; Helene Thefenne; Eric Garnotel; Gaston Tshapenda; Denis Kandolo Kakongo; Guy Kalambayi; Renaud Piarroux
Journal:  Emerg Infect Dis       Date:  2015-05       Impact factor: 6.883

Review 3.  Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia.

Authors:  B A Rahman; M O Wasfy; M A Maksoud; N Hanna; E Dueger; B House
Journal:  New Microbes New Infect       Date:  2014-06-27

4.  Patterns in antimicrobial susceptibility of Salmonellae isolated at a tertiary care hospital in northern India.

Authors:  Preeti Behl; Varsha Gupta; Atul Sachdev; Vishal Guglani; Jagdish Chander
Journal:  Indian J Med Res       Date:  2017-01       Impact factor: 2.375

Review 5.  Molecular epidemiology of fluoroquinolone resistant Salmonella in Africa: A systematic review and meta-analysis.

Authors:  Getachew Tadesse; Tesfaye S Tessema; Getenet Beyene; Abraham Aseffa
Journal:  PLoS One       Date:  2018-02-12       Impact factor: 3.240

6.  A systematic review of antimicrobial resistance of typhoidal Salmonella in India.

Authors:  Carl D Britto; Jacob John; Valsan P Verghese; Andrew J Pollard
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

7.  Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India.

Authors:  Ashwini Choudhary; Ram Gopalakrishnan; P Senthur Nambi; V Ramasubramanian; K Abdul Ghafur; M A Thirunarayan
Journal:  Indian J Med Res       Date:  2013-04       Impact factor: 2.375

8.  Fever of unknown origin attributable to haematocolpos infected with Salmonella enterica Serotypetyphi resistant to nalidixic acid: a case report.

Authors:  Sonal Saxena; Mayank Dwivedi; Priyam Batra; Renu Dutta
Journal:  J Health Popul Nutr       Date:  2013-09       Impact factor: 2.000

9.  Response of extensively drug resistant Salmonella Typhi to treatment with meropenem and azithromycin, in Pakistan.

Authors:  Sonia Qureshi; Abdullah B Naveed; Mohammad Tahir Yousafzai; Khalil Ahmad; Sarwat Ansari; Heeramani Lohana; Aimen Mukhtar; Farah Naz Qamar
Journal:  PLoS Negl Trop Dis       Date:  2020-10-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.